|
Oct 3
|
Exploring High Growth Tech Stocks In The US October 2024
|
|
Sep 6
|
Four Biotech Stocks Rally Toward Buy Points As Funds Load Up
|
|
Sep 6
|
Mirum Pharmaceuticals (MIRM) Up 4.5% Since Last Earnings Report: Can It Continue?
|
|
Aug 29
|
High Growth Tech Stocks To Watch In August 2024
|
|
Jul 31
|
Mirum Pharmaceuticals to Announce Second Quarter 2024 Financial Results and Host Conference Call on August 7, 2024
|
|
Jul 29
|
Mirum Pharmaceuticals (MIRM) Surges 7.3%: Is This an Indication of Further Gains?
|
|
Jul 25
|
Mirum’s LIVMARLI Now Approved for PFIC in Patients 12 Months and Older
|
|
Jun 18
|
Mirum (MIRM) Soars on Interim Data From Liver Disease Studies
|
|
Jun 18
|
Mirum Pharmaceuticals (MIRM) Soars 27.3%: Is Further Upside Left in the Stock?
|
|
Jun 17
|
Mirum Pharmaceuticals Advances after Reporting Positive Trial Results for Prospective Cholangitis Treatment
|
|
Jun 17
|
Mirum’s Volixibat Achieves Positive Interim Analyses in VANTAGE PBC and VISTAS PSC Studies
|
|
Jun 16
|
Mirum Pharmaceuticals to Host Investor Call to Share Interim Analysis Results from the Volixibat VANTAGE and VISTAS studies on June 17, 2024
|
|
Jun 7
|
Why Is Mirum Pharmaceuticals (MIRM) Down 3.4% Since Last Earnings Report?
|
|
Jun 6
|
Long-Term Data from Mirum’s LIVMARLI Studies in ALGS and PFIC Highlighted at EASL Congress
|
|
Jun 5
|
Mirum Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
|
|
May 18
|
Mirum Pharmaceuticals’ LIVMARLI Data Showcased at ESPGHAN Annual Meeting
|
|
May 13
|
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q1 2024 Earnings Call Transcript
|
|
May 10
|
Mirum Pharmaceuticals Inc (MIRM) Q1 2024 Earnings: Misses Revenue Forecasts, Posts Wider Net Loss
|
|
May 9
|
Mirum's (MIRM) Q1 Earnings & Revenues Fall Shy of Estimates
|
|
May 9
|
Q1 2024 Mirum Pharmaceuticals Inc Earnings Call
|